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Abstract 35 
The measurement of illicit drug metabolites in raw wastewater is increasingly being adopted 36 
as an approach to objectively monitor population-level drug use, and is an effective 37 
complement to traditional epidemiological methods. As such, it has been widely applied in 38 
western countries. In this study, we utilised this approach to assess drug use patterns over 39 
nine days during April 2011 in Hong Kong. Raw wastewater samples were collected from the 40 
largest wastewater treatment plant serving a community of approximately 3.5 million people 41 
and analysed for excreted drug residues including cocaine, ketamine, methamphetamine, 3,4-42 
methylenedioxymethamphetamine (MDMA) and key metabolites using liquid 43 
chromatography coupled with tandem mass spectrometry. The overall drug use pattern 44 
determined by wastewater analysis was consistent with that seen amongst people coming into 45 
contact with services in relation to substance use; among our target drugs, ketamine 46 
(estimated consumption: 1400–1600 mg/day/1000 people) was the predominant drug 47 
followed by methamphetamine (180–200 mg/day/1000 people), cocaine (160–180 48 
mg/day/1000 people) and MDMA (not detected). The levels of these drugs were relatively 49 
steady throughout the monitoring period. Analysing samples at higher temporal resolution 50 
provided data on diurnal variations of drug residue loads. Elevated ratios of cocaine to 51 
benzoylecgonine were identified unexpectedly in three samples during the evening and night, 52 
providing evidence for potential dumping events of cocaine. This study provides the first 53 
application of wastewater analysis to quantitatively evaluate daily drug use in an Asian 54 
metropolitan community. Our data reinforces the benefit of wastewater monitoring to health 55 
and law enforcement authorities for strategic planning and evaluation of drug intervention 56 
strategies. 57 
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1. Introduction 61 
Illicit drug consumption is among the top 20 contributors to the global burden of disease and 62 
injury [1] and has a substantial negative economic impact [2]. As such, systematic 63 
surveillance of the extent of substance use and changes over time is important, particularly, to 64 
plan and to determine the success of law enforcement and health intervention strategies [3].  65 
 66 
Hong Kong is one of the most densely populated cities in the world and its role as one of the 67 
key international financial centres draws a large number of international visitors each year.  68 
With such dynamic flow in people of different nationalities and high efficiencies in finance 69 
and transportation exchanges, Hong Kong is attractive for drug trafficking organisations [4]; 70 
for example, Hong Kong is found a key embarkation point for drugs to other Asian cities 71 
from China where illegal drug manufacturing appears often active [5].  72 
 73 
The Narcotics Division of the Security Bureau in Hong Kong reports trends in substance use 74 
through its “Central Registry of Drug Abuse (CRDA)” reports. This report compiles data 75 
from law enforcement agencies (all arrests for substance use), drug rehabilitation and 76 
treatment centres, welfare and social work services (where substance use is suspected in 77 
clients) and hospitals (where withdrawal syndromes are present or individuals self-identify); 78 
and demographic and substance use information is collected [6]. The figures recorded in the 79 
CRDA are based on those drug consumers who have been identified with the agencies 80 
reporting in the system. While this dataset is the primary source for understanding drug use 81 
trends in Hong Kong, it is highly likely that many consumers may not be identified through 82 
this system. For example, for a population of seven million, just 12,400 consumers were 83 
identified for the 2010 CRDA report: <0.2% of the total population, which is extremely low 84 
by global standards (3.4-6.6% of adults) [3]. It is likely that infrequent consumers will not 85 
come into contact with the reporting agencies. The majority of consumers identified in CRDA 86 
were unemployed and had low education levels, suggesting that the consumers in other 87 
  
demographics are not well captured by the system. To obtain more comprehensive 88 
information about substance use, multiple methods can help overcome the limitations of 89 
individual datasets [7]. 90 
 91 
An alternative method to estimate drug use is the quantification of drug metabolite residues in 92 
raw wastewater sampled at inlets of wastewater treatment plants. The feasibility of this 93 
approach – in this paper subsequently referred as wastewater analysis – to back-estimate drug 94 
consumption has been widely demonstrated [e.g. 8, 9, 10]. The basic concept of the approach 95 
is that excreted drug residues are collectively delivered from toilet systems to wastewater 96 
treatment plants in a catchment. Thus, a raw wastewater sample represents a pool of the 97 
excreted drug residues within a population and allows tracing back per capita consumption 98 
rates in the catchment. Daily composite samples are commonly collected for understanding 99 
day-to-day changes in population’s drug use; higher consumption is typically identified in 100 
weekends than weekdays [e.g. 11, 12-16]. Analysing shorter time periods allows evaluating 101 
intra-daily variations in drug use [17, 18]. Such diurnal monitoring to date is less common in 102 
the literature.  103 
 104 
Despite the fact that this approach cannot reveal patterns of individual drug use such as dose 105 
or the presence of poly-drug use, the final estimates from wastewater analysis are objective 106 
and maintain the anonymity of individual consumers. Hence, it produces less ethical issues 107 
compared to traditional epidemiological methods such as self-reporting surveys [19]. Another 108 
benefit of wastewater analysis is that it provides information about the use of chemically 109 
specified substances, which is particularly relevant to tablets sold as ‘ecstasy’, which may 110 
vary substantially in purity and content over time without the knowledge of the consumers 111 
[20, 21]. As such, wastewater analysis has been widely applied across different cities in 112 
western countries such as Australia, Canada, Europe and North America [e.g. 18, 22-28] but 113 
to date has not been conducted in any Asian communities.  114 
  
 115 
In this study, we applied wastewater analysis to estimate the extent of use of ketamine, 116 
cocaine, methamphetamine and MDMA over nine days in the major urban community of 117 
Hong Kong. The data was then compared with that from the existing CRDA drug reporting 118 
system. Additionally, we examined diurnal variations of drug residue loads in the community 119 
through analysis of two-hourly composite wastewater samples. 120 
 121 
122 
  
2. Materials and methods 123 
2.1 Wastewater sampling 124 
Samples were collected at the inlet of the largest wastewater treatment plant (WWTP) in 125 
Hong Kong. It serves approximately 3.5 million people, which is about half of the local 126 
population living in the mainly urban catchment. The WWTP is fed by two main inlet pipes 127 
(channel A and channel B) receiving wastewater from seven preliminary treatment works 128 
(PTWs). These PTWs physically remove coarse particles and sediments (screening and de-129 
gritting) and continuously pump the wastewater to the WWTP under study. The average 130 
overall hydraulic residence time of wastewater collected and pumped into the WWTP through 131 
channel A is approximately three hours and four hours for channel B. The sewer layout and 132 
hydraulic properties provide considerable mixing of wastewater and attenuation of short-term 133 
concentration variations facilitating the collection of representative samples. Samples were 134 
collected throughout the working week in 2011 on April 14
th
, 17
th–21st and 24th–28th, 135 
representing the weekdays Sunday through Thursday. Unfortunately, samples from Fridays 136 
and Saturdays are missing since the WWTP does not conduct routine sampling on weekends 137 
and does not allow access for non-staff.   138 
 139 
Hourly raw wastewater composite samples were collected at both inlet channels applying a 140 
time-proportional sampling mode, 250 mL every 15 minutes. With a few exceptions, intra-141 
hour flow coefficient variations (CV) were relatively small: 3.6–53% (channel A) and 1.2–142 
29% (channel B) (Fig. S1 and Table S1). Individual hourly samples were flow-proportionally 143 
mixed onsite in the laboratory of the WWTP to obtain representative daily composite samples 144 
for both channels. Additionally, to assess diurnal variations, the hourly samples from channel 145 
B were mixed flow-proportionally to two-hour composite samples on April 24
th
 to 28
th
. Milli-146 
Q water samples were prepared and put aside during the sample composition process as field 147 
blanks for quality control. Samples were preserved at pH 2 using 2M hydrochloride acid and 148 
frozen until analysis. The method of preservation has been widely applied and demonstrated 149 
  
to stabilise target analytes in wastewater during storage [29-31]. 150 
 151 
2.2 Materials and chemical analysis 152 
Reference materials, sample preparation and analytical measurement applied in this study 153 
have been previously reported [32]. Briefly, cocaine, benzoylecgonine, amphetamine, 154 
methamphetamine, 3,4-methylenedioxymethamphetamine (MDMA), ketamine and 155 
norketamine, together with their corresponding deuterated analogues, were purchased from 156 
Cerilliant (USA) (purities ≥ 99%). Methanol and acetonitrile (LC grade) were purchased 157 
from Merck (Germany) while hydrochloric acid (37%), formic acid and acetic acid were 158 
purchased from Sigma Aldrich (Australia).   159 
 160 
Samples were filtered (0.45 μm, RC, Phenomenex) before spiking with deuterated standards 161 
(i.e. internal standards, 1–10 ng/mL) and then analysed together with seven calibration 162 
standards (0.05, 0.1, 0.5, 1, 5, 10, 50 ng/mL) using liquid chromatograph (Shimadzu Nexera 163 
UHPLC system, Kyoto, Japan) coupled with tandem mass-spectrometry (AB SCIEX 164 
QTRAP
®
5500, Ontario, Canada) (LC-MS/MS). Targeted analytes were chromatographically 165 
separated using a Luna C18 column, 3 µm, 150X2 mm, (Phenomenex, Torrance, CA). 166 
Scheduled multiple reaction monitoring with positive electrospray ionisation were operated to 167 
identify and quantify the masses of analytes (see Lai et al. [32] for details of analytical 168 
conditions).  169 
 170 
For quality assurance and control of the analysis, duplicate samples and wastewater matrix 171 
spiked with native chemicals (1 ng/mL) were arranged for analysis. Also, blank samples of 172 
Milli-Q water were included to check for contamination in every batch of sample preparation 173 
and analysis. Milli-Q water samples were spiked with native chemicals as procedural 174 
recovery checks. The coefficient variation (CV) of duplicate samples was on average <6% 175 
(n=5). No target chemicals were quantified in the blank samples and field blank samples 176 
  
(Table S1). Procedural and matrix spike recoveries were on average in a range of 97–110% 177 
(CV: 4–16%; n=3) and 89–104% (CV: 8–27%; n=5), respectively, and inter-day analytical 178 
variability (2 days; n=8) was in a CV range of 2–9% (Table S2). Average recoveries of 179 
individual internal standards in the samples were in a range of 62–120% (CV: 5–15%; n=77) 180 
(Table S3). 181 
 182 
2.3 Targeted drug residues 183 
Seven drug residues, including parent drugs and/or its major metabolites, were targeted. 184 
These are methamphetamine, amphetamine, cocaine, benzoylecgonine, ketamine, 185 
norketamine and MDMA. The drugs have been reported to be commonly consumed in Hong 186 
Kong [6] and are regulated under Schedule 1 of the Dangerous Drugs Ordinance in the Laws 187 
of Hong Kong [33], meaning that use is illegal without authorised licenses. 188 
 189 
2.4 Back calculation of drug consumption 190 
The back calculation method was based on the model previously proposed [11] and has been 191 
commonly applied in the literature [e.g. 23, 26, 28]. A mass load of a given chemical was 192 
estimated by multiplying concentrations by the wastewater flow. The figure is then multiplied 193 
with a correction factor which comprised of the average urinary excretion rate and molecular 194 
mass ratio of a parent drug to its metabolite. The correction factor of 3.14 (1.1/0.35) was used 195 
to back estimate cocaine consumption. This was derived from the average excretion rate of 196 
cocaine to benzoylecgonine (35%, covering administration routes of smoking, snorting and 197 
injection) [34-36] and the molecular weight ratio of cocaine to benzoylecgonine (1.1). 198 
Similarly, the average excretion of methamphetamine itself (33%, covering administration 199 
routes of oral, smoking, snorting and injection) [37, 38] was used to calculate the correction 200 
factor of 4.06 (1.0/0.33) for back estimating methamphetamine consumption. The correction 201 
factor of 65 (1.06/0.016) was used to estimate ketamine consumption based on its metabolite 202 
norketamine (1.6%, injection) [37, 39, 40]. Daily drug loads and consumption in the entire 203 
  
catchment was estimated from the sum of measured drug residue loads in both channels. The 204 
data was normalised to the total population (3.5 million people). 205 
206 
  
3. Results and discussion 207 
With the collected samples representative of half the Hong Kong population, the results are 208 
adequate to provide an understanding of the illicit drug use profile in this metropolitan city. 209 
Additionally, the catchment area covers about 60% of the residential addresses of the reported 210 
drug consumers in the Central Registry of Drug Abuse (CRDA) report, which is the primary 211 
source for drug use trends in Hong Kong. Our results revealed patterns of inter- and intra-day 212 
variability in illicit drug residues through analysis of daily and two-hourly composite raw 213 
wastewater samples in Hong Kong. This contributes, in part, to addressing the paucity of 214 
literature describing wastewater analysis of illicit drug use in Asian communities.  215 
 216 
3.1 Daily drug use patterns detected in wastewater samples 217 
Five out of seven illicit drug residues were quantified in all the samples (Fig. 1). Among the 218 
drug residues, the daily load (average±standard deviation of the nine-day monitoring) of 219 
ketamine (290±27 mg/day/1000 people) was the greatest and about one order of magnitude 220 
higher than its metabolite, norketamine (23±4 mg/day/1000 people). The daily load of 221 
methamphetamine was the next highest (62±4 mg/day/1000 people). The load of cocaine 222 
(33±4 mg/day/1000 people) was approximately half that of its metabolite, benzoylecgonine 223 
(54±3 mg/day/1000 people). Amounts of amphetamine and MDMA were below the limit of 224 
detection (<10 mg/day/1000 people) in any of the samples. The load of each drug residue was 225 
steady from day to day during the monitoring period (coefficient of variations is relatively 226 
low: 5–17%). Thus, intra-week variations in drug use were not apparent. It should be noted 227 
that the weekly drug use pattern in this study comprised of four weekdays and only Sundays 228 
on the weekends, but still was inconsistent to a range of previous wastewater studies showing 229 
higher drug use during weekends than weekdays with a peak use particularly found on 230 
Sundays [e.g. 11, 13, 15]. This may suggest that regular and chronic users may be more 231 
predominant than infrequent consumers in this community.  232 
 233 
  
3.1.1 Comparison with the CRDA report 234 
The daily drug use pattern (ketamine > methamphetamine > cocaine > MDMA) detected by 235 
wastewater analysis conformed to the CRDA report [6]. In 2011, the pattern of illicit 236 
substance consumers identified in the CRDA was heroin (52% of cases) > ketamine (32%); 237 
methamphetamine (14%) > benzodiazepines and related substances (11%) > cocaine (8%) > 238 
cannabis (4%) > ecstasy (1%) [41]. While heroin is predominant (50% of consumers 239 
identified in CRDA in 2010), reports of ketamine use have quickly escalated, doubling 240 
between 2001 and 2010 to the point that one-third of consumers identified in the CRDA 241 
report were ketamine consumers. Rates of ketamine use are substantially greater than that of 242 
ecstasy, and rates of ecstasy use have been steadily declining since 2005 [6]. This high rate of 243 
ketamine use among illicit substance consumers in Hong Kong is relatively unique 244 
internationally [42]. Compared to ecstasy, ketamine is more readily available, less costly [5], 245 
higher and more consistent in purity [43-45] and easy to sociably share with others due to its 246 
distribution in powder form. This study found that mass loads of methamphetamine were 247 
consistently greater than those of amphetamine in the samples. This is in agreement to the 248 
finding in CRDA and also in United Nations Office on Drugs and Crime reporting that 249 
methamphetamine is the most widely used amphetamine-related substance in East and 250 
Southeast Asia, mainly due to its easy production process and high availability of the 251 
precursors [46, 47]. 252 
 253 
3.1.2 Comparison with other wastewater studies 254 
Estimated consumption of ketamine was predominated (1500±240 mg/day/1000 people), 255 
followed by methamphetamine (190±11 mg/day/1000 people) and cocaine (170±11 256 
mg/day/1000 people) (Fig. 2). Compared to the wastewater study across 19 European cities in 257 
2011, the average methamphetamine consumption in Hong Kong was estimated at about two 258 
to ten times higher than that in London (the U.K.), Stockholm (Sweden), Valencia (Spain) 259 
and Milan (Italy), but at about three to five times lower than that in Oslo (Norway) and 260 
  
Helsinki (Finland) [23]. The estimated consumption of methamphetamine in Hong Kong was 261 
on average similar to that in other wastewater studies in Australian communities [28, 48]. A 262 
different pattern of cocaine consumption among these countries was observed. The estimated 263 
consumption of cocaine in Hong Kong was three to ten times lower than the cities in the west 264 
and central of Europe and London but similar to the northern European cities, including Oslo, 265 
Stockholm and Helsinki [23]. Cocaine consumption was estimated to be two and six times 266 
more in Hong Kong than in the Australian urban communities of southeast Queensland [28] 267 
and Adelaide in South Australia [48], respectively. Such comparison of drug consumption 268 
across different major and urban cities worldwide demonstrates that wastewater analysis 269 
provides a standardised platform to equally gauge international drug use levels. This kind of 270 
data is rare in national and/or international drug monitoring systems but is valuable for any 271 
law enforcement authorities to estimate the rate of growth of the drug markets among various 272 
types of communities within a country or around the world.  273 
 274 
3.2 Diurnal variations in drug residue loads 275 
Drug residue concentrations and loads are plotted together in Figure 3 to facilitate the 276 
interpretation of diurnal variations: parent compounds and metabolites follow similar patterns 277 
throughout the four monitoring days (see Table S4 for total loads). The mass loads of the drug 278 
residues peaked in the mornings and at nights every day. The morning peak was generally 279 
apparent over two to four hours (7–9AM and/or 9–11AM), accounting for about 10–14% of 280 
the total mass load per two-hour period. The night peak extended four to six hours, starting in 281 
the evening (about 7PM) until midnight, reflecting approximately 10–15% of the total mass 282 
load per two-hour period. Similar wastewater studies with high resolution sampling was also 283 
conducted in Oslo, Norway (six-hour composite samples) [17] and the United States (one-284 
hour composite samples) [18]. The variation of diurnal patterns among the international 285 
studies and this study broadly suggests that drug excretion rates were often higher during 286 
mornings and selectively during evenings. The daily mass loads of drug residues estimated 287 
  
from physical daily composite sample and the sum of 12 two-hourly composite samples 288 
allow verifying the flow-proportional mixing process of individual samples. The deviations 289 
are within the expected range of analytical uncertainty and do not show any systematic 290 
deviations (Tables S5–6). 291 
 292 
3.3 Ratio of a parent drug to its metabolite 293 
The concentration ratio of the parent drug to its metabolite remained consistent in the 294 
analysed daily composite samples (ketamine/norketamine: 13±1.8; cocaine/benzoylecgonine: 295 
0.61±0.08). However, three data points from the two-hourly samples were identified as 296 
outliers (Fig. 4): the cocaine/benzoylecgonine ratios were 1.05 and 1.52, rather than the usual 297 
value observed in this community. This may imply that part of the cocaine identified in these 298 
samples could be attributed to direct dumping events rather than human metabolism. These 299 
time points were between Monday midnight and Tuesday morning (April 25th-26th; 11PM–300 
3AM) and on Tuesday night (April 26th; 7–9PM) (Fig. 3B). Such high resolution data of 301 
wastewater analysis could provide more information on drug use activities in the sewer 302 
catchment than daily composite samples. Direct dumping of cocaine can be due to different 303 
reasons, such as raids by police forces and/or hand-washing after handling cocaine. 304 
 305 
3.4 Methodological limitations  306 
While our study provides drug use data that complements the existing epidemiology reports, 307 
a few methodological constraints should be remarked for better interpretation of the results. 308 
Recent studies have proposed different human markers to estimate the number of people 309 
contributed in a wastewater sample for better estimation of per capita illicit drug use [18, 32, 310 
49]; for example, our previous study suggested the use of a certain prescription 311 
pharmaceutical [32]. However, these kinds of pharmaceutical data are not readily available in 312 
Hong Kong for estimating the population that contributed to a sample. As such, we had to 313 
rely on a nominal figure for the population contributing to the wastewater treatment plant and 314 
  
assumed that this population was consistent throughout the study period. Another issue, 315 
which also requires pharmaceutical data and thus limits this study, is to exclude potential 316 
contributions from legal sources of methamphetamine in wastewater samples as 317 
methamphetamine can be metabolised after prescribing selegiline for diagnosing Parkinson’s 318 
disease [15, 28]. However, this may only produce a minor influence on the data presented 319 
here; studies showed that Parkinson’s disease is less prevalent in Hong Kong than Australian 320 
communities [50]. Regarding the use of literature-based pharmacokinetic data for 321 
extrapolating drug use, there are two notable limitations: (a) the currently available studies 322 
reporting urinary excretion values were mainly conducted in Western countries, and thus 323 
cannot account for possible variations in metabolism due to different racial demographics (i.e. 324 
potential differences in people of Asian descent in comparison to Western samples); and (b) 325 
smaller urinary excretion fractions potentially increase uncertainty levels of estimations, 326 
particularly in the back-estimation of ketamine use from norketamine. Lastly, this study only 327 
monitored drug use across about two weeks and thus the results cannot be generalised to 328 
patterns of drug use over the whole year in Hong Kong.   329 
 330 
4. Conclusions 331 
This study for the first time applied wastewater analysis to quantitatively determine the level 332 
of drug use between and within days in an Asian metropolitan community. The overall pattern 333 
of drug use detected in daily wastewater samples was consistent with that in the current drug 334 
reporting system. Elevated concentration ratios of cocaine to benzoylecgonine were identified 335 
in three samples of the high-temporal resolution diurnal monitoring, suggesting possible 336 
dumping events of cocaine. Given that the current drug reporting system in Hong Kong only 337 
obtains limited data from drug users identified by health and law enforcement, setting up 338 
more sophisticated national monitoring systems with wastewater analysis as complementary 339 
means can provide more comprehensive assessments on drug use. These are valuable for 340 
health and law enforcement authorities to strategically plan and systematically evaluate the 341 
  
effectiveness of drug use intervention programmes in the community. 342 
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Figure 1: Comparison of weekly variation in daily mass loads (mg/day/1000 people) of the 501 
targeted drug residues. Concentrations of amphetamine and MDMA were below detection 502 
limits (< 10 mg/day/1000 people). Sampling dates included 14
th
, 17
th–21st and 24th–28th April 503 
in 2011 (n=2 per weekday; the error bar indicates a single standard deviation of the two 504 
samples). Samples from Fridays and Saturdays are missing because the wastewater treatment 505 
plant does not carry out the routine sampling and does not allow access for non-staff on these 506 
two days.  507 
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Figure 2: Estimated consumption (mg/day/1000 people) of ketamine, methamphetamine and 513 
cocaine in the studied community. Sampling dates included 14
th
, 17
th–21st and 24th–28th April 514 
in 2011 (n=2 per weekday; the error bar indicates a single standard deviation of the two 515 
samples). Samples from Fridays and Saturdays are missing because the wastewater treatment 516 
plant does not carry out the routine sampling and does not allow access for non-staff on these 517 
two days. 518 
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 522 
Figure 3: Diurnal variations of drug residues (dt = 2 h). Right Y-axis: drug residue 523 
concentrations (dashed lines). Left Y-axis: Percentage of total daily drug residue loads 524 
  
(coloured solid lines) and percentage of the total wastewater flow (black solid line). Total 525 
wastewater flow and mass loads for each drug are reported in Table S4. An error bar included 526 
the uncertainty of chemical analysis, sampling and/or flow measurement (Table S6) [32]. 527 
